<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In recent years, Pneumocystis carinii <z:hpo ids='HP_0002090'>pneumonia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>) has been increasingly reported in patients without human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The increased occurrence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> in non-HIV-immunocompromised subjects has been attributed to several factors: use of stronger immunosuppressive regimens, higher awareness of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>, advanced diagnostic technology and nosocomial spread of P. carinii </plain></SENT>
<SENT sid="2" pm="."><plain>Appearance of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> subsequent to the use of immunosuppressive drugs has been noticed in many <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> such as <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Dermatologists frequently use immunomodulating agents, but the occurrence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> in patients receiving immunosuppressive drugs for <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">skin diseases</z:e> is largely unknown </plain></SENT>
<SENT sid="4" pm="."><plain>We report four cases where <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> appeared following the use of immunosuppressive drugs primarily for cutaneous diseases, namely <z:e sem="disease" ids="C0030807" disease_type="Disease or Syndrome" abbrv="">pemphigus</z:e>, cutaneous necrotizing <z:hpo ids='HP_0002633'>vasculitis</z:hpo> (two cases) and <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's syndrome </plain></SENT>
<SENT sid="5" pm="."><plain>These cases were identified in a computerized database study (1979-95) to evaluate the occurrence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e> among immunocompromised hosts without <z:e sem="disease" ids="C0019693" disease_type="Disease or Syndrome" abbrv="">HIV infection</z:e> </plain></SENT>
</text></document>